Now showing items 1-1 of 1

    • Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda 

      Sacktor, N; Nakasujja, N; Skolasky, R. L.; Robertson, K.; Musisi, S; Ronald, A; Katabira, E; Clifford, D. B. (American Academy of Neyurology, 2009)
      Background: The frequency of HIV dementia in a recent study of HIV individuals at the Infectious Disease Institute in Kampala, Uganda, was 31%. Coformulated generic drugs, which include stavudine, are the most common ...